✦ LIBER ✦

The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer

Book ID: 123292938
Publisher: Elsevier Science
Year: 1996
Tongue: English
Weight: 143 KB
Volume: 16
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)89513-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic significance of CCND1 (cyclin

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 271 KB

Prognostic value of serum p53 antibodies

Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer

✍ Laudanski, Jerzy; Burzykowski, Tomasz; Niklinska, Wieslawa; Chyczewski, Lech; Fu 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Prognostic value of cyclin D1 overexpres

Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC)

✍ Dorota Dworakowska; Ewa Jassem; Jacek Jassem; Carsten Boltze; Klaus Hermann Wied 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 334 KB

Prognostic value of p53 abnormalities in

Prognostic value of p53 abnormalities in non-small cell lung cancer (NSCLC)

✍ J. Niklinski; L. Chyczewski; W. Niklinska; J. Laudanski; M. Furman 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Lack of prognostic value ofEGFRmutations

Lack of prognostic value ofEGFRmutations in primary resected non-small cell lung cancer

✍ Ken-Hong Lim; Ming-Jer Huang; Hung-Chang Liu; Hsu-Tah Kuo; Chin-Yuan Tzen; Ruey- 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 153 KB

Quantitative analysis of p53 protein in

Quantitative analysis of p53 protein in non-small cell lung cancer and its prognostic value

✍ Michael A. Levesque; Mario D'Costa; Ernest H. Spratt; Mohammad M. Yaman; Elefthe 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 99 KB 👁 2 views

Accumulation of mutant p53 protein occurs frequently in human malignancies, including 40-60% of non-small cell lung carcinomas. The implications of such p53 over-expression, usually assessed by immunohistochemical techniques, for the prognosis of lung cancer patients remain undetermined. In this stu